2012
DOI: 10.1016/j.freeradbiomed.2012.08.007
|View full text |Cite
|
Sign up to set email alerts
|

Administration of nitrite after chlorine gas exposure prevents lung injury: Effect of administration modality

Abstract: Cl2 gas toxicity is complex and occurs during, and post exposure leading to acute lung injury (ALI) and reactive airway syndrome (RAS). Moreover, Cl2 exposure can occur in diverse situations encompassing mass casualty scenarios underscoring the need for post-exposure therapies that are efficacious and amenable to rapid and easy administration. In this study, we compared the efficacy of a single dose, post (30min) Cl2 exposure administration of nitrite (1mg/kg) via intraperitoneal (IP) or intramuscular (IM) inj… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

6
31
0

Year Published

2014
2014
2022
2022

Publication Types

Select...
9

Relationship

6
3

Authors

Journals

citations
Cited by 30 publications
(37 citation statements)
references
References 43 publications
(65 reference statements)
6
31
0
Order By: Relevance
“…There are of course significant differences between Cl 2 and ozone gas toxicity, with respect to acute symptoms, airway penetration, and sequelae (70,73). Nevertheless, both agents cause significant oxidative injury to airway epithelium and increase airway resistance and hyperresponsiveness to methacholine, which last for days postexposure (2,15,21,23,30,60,65,67); furthermore, workers exposed to ozone or chlorine both report a significant increase in acute wheezing episodes (27). In both cases there is increased generation of reactive intermediates, which lasts after the cessation of exposure.…”
Section: Discussionmentioning
confidence: 99%
“…There are of course significant differences between Cl 2 and ozone gas toxicity, with respect to acute symptoms, airway penetration, and sequelae (70,73). Nevertheless, both agents cause significant oxidative injury to airway epithelium and increase airway resistance and hyperresponsiveness to methacholine, which last for days postexposure (2,15,21,23,30,60,65,67); furthermore, workers exposed to ozone or chlorine both report a significant increase in acute wheezing episodes (27). In both cases there is increased generation of reactive intermediates, which lasts after the cessation of exposure.…”
Section: Discussionmentioning
confidence: 99%
“…From 20 s up to 3 min after each aerosol challenge, resistance (centimeters of water per milliliter per second) and elastance (centimeters of water per milliliter) were recorded continuously, as previously described (38).…”
Section: Downloaded Frommentioning
confidence: 99%
“…This is followed by a postexposure injury phase occurring over a time span ranging from days to months, which affects the airways and pulmonary and systemic vasculature (9,11,20,25,26,30,37). Clinically, this presents as reactive airway syndrome, hypoxemia, noncardiogenic edema leading to acute lung injury, and development of acute respiratory distress syndrome, which chronically leads to reactive airway disease, increased sensitivity to pulmonary infections, fibrosis, and bronchiolitis obliterans, as well as dermal injury (9,10,12,17,24,26,28,30). Exciting recent studies are providing insights into the postexposure mechanisms that include increased oxidative stress, neurogenic and airway inflammation, fibrosis, loss of nitric oxide (NO) signaling homeostasis, and loss of endogenous airway repair mechanisms (2, 9 -11, 15, 20, 22, 25, 26, 36).…”
mentioning
confidence: 99%
“…Exciting recent studies are providing insights into the postexposure mechanisms that include increased oxidative stress, neurogenic and airway inflammation, fibrosis, loss of nitric oxide (NO) signaling homeostasis, and loss of endogenous airway repair mechanisms (2, 9 -11, 15, 20, 22, 25, 26, 36). This information has led to the testing and demonstration of efficacy for antioxidant therapy (9,16,22,23,37), anti-inflammatory (using corticosteroids) treatment (5), ␤2-agonists (29), phosphodiesterase inhibitors (4), transient receptor potential channel inhibitors (1,2), and strategies that improve NO bioavailability (28,36).…”
mentioning
confidence: 99%